What's New on the FDA Drugs Site
May 16, 2017
- Drug Trials Snapshots: RADICAVA
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Safety Communication: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)
- FDA Drug Shortages
- Hydroxyamphetamine Hydrobromide/Tropicamide (Paremyd) (Updated - Resolved)
- Methotrexate Sodium Injection (New - Currently in Shortage)
- Sterile Talc Powder (Updated - Updated - Currently in Shortage)
- Tolmetin Sodium Tablets, USP (New - Currently in Shortage)
- Manual of Policies and Procedures (MAPP) 6020.13 Good Review Practice: Clinical and Consultative Review of Drugs to Reduce the Risk of Cancer (PDF - 75KB) (updated)
- National Drug Code Directory
- Product-Specific Guidances for Generic Drug Development (Updated to include: 21 New; 16 Revisions)
- FY 2017 Generic Drug Research Public Workshop (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario